Study of Osimertinib in EGFR-mutant Non-small cell lung cancer patients with T790M-mutation detected by circulating tumour DNA
Latest Information Update: 11 Oct 2018
At a glance
- Drugs Osimertinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 26 Sep 2018 Results (n=82) presented at the 19th World Conference on Lung Cancer
- 27 Jan 2017 New trial record
- 18 Jan 2017 Results (n=48) published in the Annals of Oncology.